{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:54:29Z","timestamp":1784267669725,"version":"3.55.0"},"reference-count":62,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>PURA-related neurodevelopmental disorders (PURA-NDDs) are a rare genetic disease caused by pathogenic autosomal dominant variants in the PURA gene or a deletion encompassing the PURA gene. PURA-NDD is clinically characterized by neurodevelopmental delay, learning disability, neonatal hypotonia, feeding difficulties, abnormal movements, and epilepsy. It is generally considered to be central nervous system disorders, with generalized weakness, associated hypotonia, cognitive and development deficits in early development, and seizures in late stages. Although it is classified predominantly as a central nervous syndrome disorder, some phenotypic features, such as myopathic facies, respiratory insufficiency of muscle origin, and myopathic features on muscle biopsy and electrodiagnostic evaluation, point to a peripheral (neuromuscular) source of weakness. Patients with PURA-NDD have been increasingly identified in exome-sequenced cohorts of patients with neuromuscular- and congenital myasthenic syndrome-like phenotypes. Recently, fluctuating weakness noted in a PURA-NDD patient, accompanied by repetitive nerve stimulation abnormalities, suggested the disease to be a channelopathy and, more specifically, a neuromuscular junction disorder. Treatment with pyridostigmine or salbutamol led to clinical improvement of neuromuscular function in two reported cases. The goal of this systematic retrospective review is to highlight the motor symptoms of PURA-NDD, to further describe the neuromuscular phenotype, and to emphasize the role of potential treatment opportunities of the neuromuscular phenotype in the setting of the potential role of PURA protein in the neuromuscular junction and the muscles.<\/jats:p>","DOI":"10.3390\/ijms24032260","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T01:29:45Z","timestamp":1674523785000},"page":"2260","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Neuromuscular and Neuromuscular Junction Manifestations of the PURA-NDD: A Systematic Review of the Reported Symptoms and Potential Treatment Options"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8731-0540","authenticated-orcid":false,"given":"Magdalena","family":"Mroczek","sequence":"first","affiliation":[{"name":"Center for Cardiovascular Genetics & Gene Diagnostics, Foundation for People with Rare Diseases, 8952 Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Iyadurai","sequence":"additional","affiliation":[{"name":"Division of Neurology, Johns Hopkins All Children\u2019s Hospital, 501 6th Ave S, St. Petersburg, FL 33701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/jcp.24237","article-title":"The pur protein family: Genetic and structural features in development and disease","volume":"228","author":"Johnson","year":"2013","journal-title":"J. Cell Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"638217","DOI":"10.3389\/fgene.2021.638217","article-title":"The Molecular Function of PURA and Its Implications in Neurological Diseases","volume":"12","author":"Molitor","year":"2021","journal-title":"Front. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.gene.2017.12.004","article-title":"PURA, the gene encoding Pur-alpha, member of an ancient nucleic acid-binding protein family with mammalian neurological functions","volume":"643","author":"Daniel","year":"2018","journal-title":"Gene"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4161\/cc.8.3.7585","article-title":"Multiple roles for Puralpha in cellular and viral regulation","volume":"8","author":"White","year":"2009","journal-title":"Cell Cycle"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"44935","DOI":"10.1074\/jbc.M307696200","article-title":"Single-stranded DNA-binding proteins PURalpha and PURbeta bind to a purine-rich negative regulatory element of the alpha-myosin heavy chain gene and control transcriptional and translational regulation of the gene expression. Implications in the repression of alpha-myosin heavy chain during heart failure","volume":"278","author":"Gupta","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ajhg.2014.09.014","article-title":"Mutations in PURA cause profound neonatal hypotonia, seizures, and encephalopathy in 5q31.3 microdeletion syndrome","volume":"95","author":"Lalani","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/ajmg.a.35439","article-title":"Clinical phenotype and candidate genes for the 5q31.3 microdeletion syndrome","volume":"158A","author":"Hosoki","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41431-022-01217-4","article-title":"A 25 Mainland Chinese cohort of patients with PURA-related neurodevelopmental disorders: Clinical delineation and genotype-phenotype correlations","volume":"31","author":"Dai","year":"2022","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/jmedgenet-2014-102798","article-title":"Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability","volume":"51","author":"Hunt","year":"2014","journal-title":"J. Med. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/ajmg.a.33891","article-title":"A new microdeletion syndrome of 5q31.3 characterized by severe developmental delays, distinctive facial features, and delayed myelination","volume":"155A","author":"Shimojima","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_11","unstructured":"(2022, November 29). Available online: https:\/\/www.purasyndrome.org\/condition."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00401-015-1530-0","article-title":"Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity","volume":"131","author":"Daigle","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.1128\/MCB.23.19.6857-6875.2003","article-title":"Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse","volume":"23","author":"Khalili","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/hmg\/ddr476","article-title":"Lack of Pur-alpha alters postnatal brain development and causes megalencephaly","volume":"21","author":"Hokkanen","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neuroscience.2016.09.018","article-title":"Memory deficits, gait ataxia and neuronal loss in the hippocampus and cerebellum in mice that are heterozygous for Pur-alpha","volume":"337","author":"Barbe","year":"2016","journal-title":"Neuroscience"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1523\/JNEUROSCI.13-02-00834.1993","article-title":"In vivo observations of pre- and postsynaptic changes during the transition from multiple to single innervation at developing neuromuscular junctions","volume":"13","author":"Lichtman","year":"1993","journal-title":"J. Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/j.1471-4159.2008.05288.x","article-title":"Proteomic analysis of nuclear factors binding to an intronic enhancer in the myelin proteolipid protein gene","volume":"105","author":"Dobretsova","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1083\/jcb.130.5.1171","article-title":"A 39-kD DNA-binding protein from mouse brain stimulates transcription of myelin basic protein gene in oligodendrocytic cells","volume":"130","author":"Haas","year":"1995","journal-title":"J. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.neuron.2004.07.022","article-title":"Kinesin transports RNA: Isolation and characterization of an RNA-transporting granule","volume":"43","author":"Kanai","year":"2004","journal-title":"Neuron"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1091\/mbc.e16-07-0497","article-title":"Components of RNA granules affect their localization and dynamics in neuronal dendrites","volume":"28","author":"Mitsumori","year":"2017","journal-title":"Mol. Biol. Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuron.2006.08.021","article-title":"Neuronal RNA granules: Movers and makers","volume":"51","author":"Kiebler","year":"2006","journal-title":"Neuron"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.molcel.2014.07.012","article-title":"The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites","volume":"55","author":"West","year":"2014","journal-title":"Mol. Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neuropharm.2016.06.004","article-title":"Metabotropic glutamate receptor, mGlu5, regulates hippocampal synaptic plasticity and is required for tetanisation-triggered changes in theta and gamma oscillations","volume":"115","author":"Bikbaev","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fphar.2012.00199","article-title":"Translational Concepts of mGluR5 in Synaptic Diseases of the Brain","volume":"3","author":"Piers","year":"2012","journal-title":"Front. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/sj.leu.2402108","article-title":"Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia","volume":"15","author":"Najfeld","year":"2001","journal-title":"Leukemia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e1943","DOI":"10.1038\/cddis.2015.295","article-title":"Pur-alpha functionally interacts with FUS carrying ALS-associated mutations","volume":"6","author":"Piccinni","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jnr.20806","article-title":"Role of Pur alpha in targeting mRNA to sites of translation in hippocampal neuronal dendrites","volume":"83","author":"Johnson","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00401-013-1200-z","article-title":"C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci","volume":"126","author":"Mizielinska","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7778","DOI":"10.1073\/pnas.1219643110","article-title":"Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration","volume":"110","author":"Xu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e101112","DOI":"10.15252\/embj.2018101112","article-title":"RNA toxicity in non-coding repeat expansion disorders","volume":"39","author":"Swinnen","year":"2020","journal-title":"EMBO J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/jcp.24564","article-title":"The Pur\u03b1\/Pur\u03b2 single-strand DNA-binding proteins attenuate smooth-muscle actin gene transactivation in myofibroblasts","volume":"229","author":"Hariharan","year":"2014","journal-title":"J. Cell Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1093\/nar\/gkaa035","article-title":"circSamd4 represses myogenic transcriptional activity of PUR proteins","volume":"48","author":"Pandey","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0028-3908(00)00114-3","article-title":"mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia","volume":"40","author":"Walker","year":"2001","journal-title":"Neuropharmacology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.nmd.2022.06.008","article-title":"Corrigendum to \u2018Hypotonic Infant with PURA Syndrome-related Channelopathy Successfully Treated with Pyridostigmine\u2019 Neuromuscular Disorders Volume 32, Issue 2, February 2022, Pages 166-169","volume":"32","author":"Wyrebek","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e613","DOI":"10.1212\/NXG.0000000000000613","article-title":"PURA-Related Developmental and Epileptic Encephalopathy: Phenotypic and Genotypic Spectrum","volume":"7","author":"Johannesen","year":"2021","journal-title":"Neurol. Genet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ajmg.a.38521","article-title":"Expanding the neurodevelopmental phenotype of PURA syndrome","volume":"176","author":"Lee","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","article-title":"The PRISMA 2020 statement: An updated guide\u2014669 line for reporting systematic reviews","volume":"74","author":"Page","year":"2021","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.nmd.2022.09.007","article-title":"PURA syndrome: Neuromuscular junction manifestations with potential therapeutic implications","volume":"32","author":"Qashqari","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/jmedgenet-2017-104946","article-title":"PURA syndrome: Clinical delineation and genotype-phenotype study in 32 individuals with review of published literature","volume":"55","author":"Reijnders","year":"2018","journal-title":"J. Med. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/ajmg.a.36108","article-title":"5q31.3 Microdeletion syndrome: Clinical and molecular characterization of two further cases","volume":"161A","author":"Brown","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13039-015-0193-9","article-title":"Long-term follow-up of a patient with 5q31.3 microdeletion syndrome and the smallest de novo 5q31.2q31.3 deletion involving PURA","volume":"8","author":"Bonaglia","year":"2015","journal-title":"Mol. Cytogenet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"a000356","DOI":"10.1101\/mcs.a000356","article-title":"De novo mutations in PURA are associated with hypotonia and developmental delay","volume":"1","author":"Tanaka","year":"2015","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/cga.12214","article-title":"Patient with a novel purine-rich element binding protein A mutation","volume":"57","author":"Okamoto","year":"2017","journal-title":"Congenit. Anom."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/AOG.0000000000002047","article-title":"Premature Thelarche and the PURA Syndrome","volume":"129","author":"Rezkalla","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ymgme.2017.12.436","article-title":"A frame-shift deletion in the PURA gene associates with a new clinical finding: Hypoglycorrhachia. Is GLUT1 a new PURA target?","volume":"123","author":"Mayorga","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"18007","DOI":"10.1038\/hgv.2018.7","article-title":"Infantile spasms related to a 5q31.2-q31.3 microdeletion including PURA","volume":"5","author":"Shimojima","year":"2018","journal-title":"Hum. Genome Var."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pediatrneurol.2019.09.008","article-title":"PURA Syndrome and Myotonia","volume":"104","author":"Trau","year":"2020","journal-title":"Pediatr. Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12041-019-1165-3","article-title":"A novel de novo mutation in the PURA gene associated with a new clinical finding: Large brainstem","volume":"99","year":"2020","journal-title":"J. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e1263","DOI":"10.1002\/mgg3.1263","article-title":"The phenotype-driven computational analysis yields clinical diagnosis for patients with atypical manifestations of known intellectual disability syndromes","volume":"8","author":"Ciara","year":"2020","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e1562","DOI":"10.1002\/mgg3.1562","article-title":"Expanding the PURA syndrome phenotype: A child with the recurrent PURA p. (Phe233del) pathogenic variant showing similarities with cutis laxa","volume":"9","author":"Cinquina","year":"2021","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-0040-1715625","article-title":"Three Individuals with PURA Syndrome in a Cohort of Patients with Neuromuscular Disease","volume":"52","author":"Mroczek","year":"2021","journal-title":"Neuropediatrics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"194","DOI":"10.21037\/tp-20-248","article-title":"Neonatal PURA syndrome: A case report and literature review","volume":"10","author":"Liu","year":"2021","journal-title":"Transl. Pediatr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1684\/epd.2021.1328","article-title":"Early-onset bradykinetic rigid syndrome and reflex seizures in a child with PURA syndrome","volume":"23","author":"Solazzi","year":"2021","journal-title":"Epileptic Disord."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.braindev.2021.05.009","article-title":"Expanding the clinical phenotype and genetic spectrum of PURA-related neurodevelopmental disorders","volume":"43","author":"Choi","year":"2021","journal-title":"Brain Dev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/mdc3.13272","article-title":"Complex Movement Disorders in a Boy with PURA Syndrome","volume":"8","author":"Lin","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_56","first-page":"170","article-title":"PURA syndrome in a child with severe developmental delay: A challenging diagnosis","volume":"74","author":"Nogueira","year":"2022","journal-title":"Rev. Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41439-022-00189-7","article-title":"Expanding the PURA syndrome phenotype with manifestations in a Japanese female patient","volume":"9","author":"Fukuda","year":"2022","journal-title":"Hum. Genome Var."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1469-8749.2011.03918.x","article-title":"Genetic evaluation of the pediatric patient with hypotonia: Perspective from a hypotonia specialty clinic and review of the literature","volume":"53","author":"Lisi","year":"2011","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/aap.12005","article-title":"Neuromuscular blocking effect of fluoxetine and its interaction with rocuronium","volume":"33","author":"Patel","year":"2013","journal-title":"Auton. Autacoid. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cbi.2008.04.002","article-title":"Effect of fluoxetine on neuromuscular function in acetylcholinesterase (AChE) knockout mice","volume":"175","author":"Bertrand","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nurt.2007.01.001","article-title":"The therapy of congenital myasthenic syndromes","volume":"4","author":"Engel","year":"2007","journal-title":"Neurotherapeutics"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"eaaz4957","DOI":"10.1126\/scitranslmed.aaz4957","article-title":"4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2-encephalopathy","volume":"13","author":"Hedrich","year":"2021","journal-title":"Sci. Transl. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2260\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:14:12Z","timestamp":1760120052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":62,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24032260"],"URL":"https:\/\/doi.org\/10.3390\/ijms24032260","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]}}}